These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24641310)

  • 21.
    Vázquez-León P; Arenas-Martínez U; Córdova-Maqueda D; Fregoso-Aguilar T; Juan ER; Miranda-Páez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):34-42. PubMed ID: 33949161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.
    Aldrich JV; Senadheera SN; Ross NC; Reilley KA; Ganno ML; Eans SE; Murray TF; McLaughlin JP
    Br J Pharmacol; 2014 Jul; 171(13):3212-22. PubMed ID: 24588614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.
    Carlezon WA; Béguin C; DiNieri JA; Baumann MH; Richards MR; Todtenkopf MS; Rothman RB; Ma Z; Lee DY; Cohen BM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):440-7. PubMed ID: 16223871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
    Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
    Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.
    dos Santos RG; Crippa JA; Machado-de-Sousa JP; Hallak JE
    Curr Drug Abuse Rev; 2014; 7(2):128-32. PubMed ID: 25563442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.
    Bailey A; Yoo JH; Racz I; Zimmer A; Kitchen I
    J Neurochem; 2007 Sep; 102(6):1817-1830. PubMed ID: 17532787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
    Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A.
    Peet MM; Baker LE
    Behav Pharmacol; 2011 Sep; 22(5-6):450-7. PubMed ID: 21814135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
    Valenza M; Windisch KA; Butelman ER; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Apr; 237(4):1147-1160. PubMed ID: 31915862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.
    Gehrke BJ; Chefer VI; Shippenberg TS
    Psychopharmacology (Berl); 2008 Apr; 197(3):509-17. PubMed ID: 18246329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
    Grundmann O; Phipps SM; Zadezensky I; Butterweck V
    Planta Med; 2007 Aug; 73(10):1039-46. PubMed ID: 17628834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Braida D; Limonta V; Capurro V; Fadda P; Rubino T; Mascia P; Zani A; Gori E; Fratta W; Parolaro D; Sala M
    Biol Psychiatry; 2008 Feb; 63(3):286-92. PubMed ID: 17920565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
    Valenza M; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2017 Aug; 234(15):2219-2231. PubMed ID: 28550455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist.
    McCurdy CR; Sufka KJ; Smith GH; Warnick JE; Nieto MJ
    Pharmacol Biochem Behav; 2006 Jan; 83(1):109-13. PubMed ID: 16434091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.